Drug Trial Radar · NCT00243815
Use of Ibuprofen to Prevent IUD Site Effects
Last checked: Nov 19, 2026Latest source record: Oct 17, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,019
Actual
Start
Jun 2002
Primary completion
Not stated
Study completion Nov 2004
Sponsor
- Lead sponsor
- FHI 360Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Chilean Institute of Reproductive Medicine; Ministry of Health, Chile
- First posted
- Oct 25, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 49 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This research will determine whether prophylactic use of ibuprofen can prevent common side effects of the copper intrauterine device (IUD) and prevent early removal of the device.
Conditions
- IUD Removal
Interventions
ibuprofenDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- IUD removal
Locations
1 site in 1 country. Site status is shown where the registry gives one.
43 Ministry of Health facilities
Santiago, Chile
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.